The present study was conducted to evaluate the hepatoprotective activity of different extracts of Tinospora cordifolia against carbon tetrachloride (CCl 4 ) induced liver damage in rats. The pet ether, ethanol and aqueous extracts of various parts of the plant such as leaf, stem and root were tested at the dose of 200mg/kg body weight orally using Wistar albino rats and Silymarin was given as reference standard. Ethanolic extract of all the parts showed significant hepatoprotective effect by reduction in serum enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and total bilirubin (TBL) in the selected model which is followed by aqueous and pet ether extracts. The chemical constituents reported from the plant belong to different classes such as alkaloids, flavanoids, glycosides, steroids, terpenoids, phenolics and saponins. The overall experimental results suggests that the biologically active phytoconstituents such as flavonoids, alkaloids present in the ethanolic extract of plant Tinospora cordifolia, may be responsible for the significant hepatoprotective activity. Therefore, results justify the use of Tinospora cordifolia as a hepatoprotective agent.
INTRODUCTION
T inospora cordifolia (Guduchi) is a widely used plant in folk and ayurvedic systems of medicine. It is a climbing shrub belonging to the family Menispermaceae, which is widely distributed throughout Indian subcontinent and China [1] . Th e stem of Tinospora cordifolia is rather succulent with long fi liform fl eshy aerial roots from the branches. Th e bark is creamy white to grey, deeply left spirally, the space in between being spotted with large rosette like lenticels [2] . Th e stem is bitter, stomachic, diuretic [3] , stimulates bile secretion, causes constipation, allays thirst, burning sensation, vomiting, enriches the blood and cures jaundice. Th e extract of its stem is useful in skin diseases [4] [5] . Th e root and stem of T. cordifolia are prescribed in combination with other drugs as an antidote to snake bite and scorpion sting [6] [7] . Oral administration of an aqueous T. cordifolia root extract to alloxan diabetic rats caused a signifi cant reduction in blood glucose and brain lipids [8] . T. cordifolia is reported to benefi t the immune system in a variety of ways [9] . Th e hepatoprotective action of T. cordifolia was reported in one of the experiment in which goats treated with T. cordifolia have shown signifi cant clinical and hemato-biochemical improvement in CCl 4 induced hepatopathy. Extract of T. cordifolia has also exhibited in vitro inactivating property against Hepatitis B and E surface antigen [10] . Th e aqueous extract of T. cordifolia exerted a signifi cant anti-infl ammatory eff ect on cotton pellet granuloma and formalin induced arthritis models [11] . In a clinical evaluation, a compound preparation 'Rumalaya' containing T. cordifolia was reported to signifi cantly reduce the pain in patients suff ering from rheumatoid arthritis [12] .
Liver diseases are a serious health problem. In the absence of reliable liver protective drugs in allopathic medical practices, herbs play a role in the management of various liver disorders. Numerous medicinal plants and their formulations are used for liver disorders in ethnomedical practices and in traditional system of medicine in India [13] . In view of severe undesirable side eff ects of synthetic agents, there is growing focus to follow systematic research methodology and to evaluate scientifi c basis for the traditional herbal medicines that are claimed to possess hepatoprotective activity. Th e use of medicinal plants in modern medicine suff ers from the fact that though hundreds of plants are used in the world to prevent or to cure diseases, scientifi c evidence in terms of modern medicine is lacking in most cases. However today it is necessary to provide scientifi c proof as whether to justify the use of plant or its active principles [14] . So, in the present study, we investigated the hepatoprotective eff ect of various parts of T. cordifolia extracted with pet ether, ethanol and aqueous against CCl 4 induced liver damage in rats.
MATERIALS AND METHODS Plant materials and preparation of extracts
Th e diff erent parts such as leaf, stem and root of the plant Tinospora cordifolia were freshly collected in winter season locally from Bhadra Wild Life Sanctuary, Karnataka (Southern India) in February 2010. Th e taxonomic identifi cation of the plant was confi rmed by Dr. Y. L. Ramachandra, Department of Biotechnology, Kuvempu University, Shankaraghatta (Voucher specimen number YLR530), has been preserved in Dept. of Biotechnology, Kuvempu University, Shankaraghatta for future references. Th e shade dried leaves were pulverised and subjected for extraction using pet ether, ethanol (LR grade, Merck, India) and aqueous separately using soxhlet apparatus. Th en the extracts were concentrated using rotary fl ash evaporator (Buchi Flawil, Switzerland). Th e suspension of extracts were prepared using 5% gum acacia and used for the study.
Preliminary phytochemical analysis
All the diff erent extracts were then subjected to preliminary phytochemical analysis to assess the presence of various phytoconstituents [15] . 
Animal models
Studies were carried out using Wistar strain albino rats (150-200 g) of either sex, which were procured from Central Animal House, National College of Pharmacy, Shivamogga. Th ey were housed under standard laboratory conditions (temp 23±2oC, relative humidity 55±10%) with dark light circle (14/10hr). Animals were allowed free access to standard pellet diet (Sai Durga Feeds, Bangalore) and water ad libitum. All experimental protocols were prepared and performed based on ethical guidelines of Institutional Animal Ethics Committee (No. 144/1999/ CPCSEA/SMG).
Toxicity studies
Acute toxicity study was performed for all the extracts according to the staircase method of Ghosh [16] . Female albino rats were used for acute toxicity study. Th e animals were kept fasting for overnight providing only water, after which the extract was administered orally at doses of 100, 200 and 300mg/kg b.w. and observed for toxic symptoms up to 72 h. 200 mg/kg b.w was taken as the therapeutic oral dose for all the extracts.
Carbon tetrachloride induced hepatotoxicity
Rats were divided into twelve groups of six animals each. Th e rats of control group (I) received three doses of 5% gum acacia mucilage (1ml/kg b.w.) at 12 h intervals (0 h, 12 h and 24 h). Th e rats of CCl 4 group (II) received three doses of vehicle at 12 h intervals and a single dose of CCl 4 (1.25ml/kg b.w.) diluted in liquid paraffi n (1:1) 30 minutes after the administration of 1 st dose of vehicle. Group -III served as reference control, received silymarin (25mg/kg b.w.) once daily for 3 days. Group -IV to XII received, T. cordifolia extract (200 mg/kg b.w.) once daily for 3 days. Group III to XII received CCl 4 (3gm/kg b.w.) as single dose on day 3, thirty minutes after the administration of extracts and silymarin respectively. All the test drugs and CCl 4 were administered orally by suspending in 5% gum acacia mucilage. After 36 hour of administration of CCl 4 , blood was collected by direct cardiac puncture under light ether anesthesia and serum was separated and used for determination of biochemical parameters such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and total bilirubin (TBL) [17] .
Histopathological studies
Th e animals were sacrifi ced and the abdomen was cut open to remove the liver. Th e liver was fi xed in Bouin's solution (mixture of 75 ml of saturated picric acid, 25 ml of 40% formaldehyde and 5ml of glacial acetic acid) for 12h, and then embedded in paraffi n using conventional methods [18] and cut into 5μm thick sections and stained using haematoxylin-eosin dye and fi nally mounted in di-phenyl xylene. Th e sections were then observed under microscope for histopathological changes in liver architecture and their photomicrographs were taken.
Statistical analysis
Statistical analysis of the data was done by one-way ANOVA, followed by student t-test using software ezANOVA ver. 0.98. Th e level of signifi cance was fi xed at P<0.05.
RESULTS AND DISCUSSION
Th e preliminary phytochemical investigations show the presence of various secondary metabolites as tabulated in table 1. Th e same extracts have shown significant hepatoprotective activities at the concentration (200 mg/kg) tested, although its pure form remains to be studied. Th e results of biochemical parameters revealed the elevation of enzyme level in CCl 4 treated group, indicating that CCl 4 induces damage to the liver ( Table 2) . A signifi cant reduction was observed in TBL, ALT, AST and ALP levels in the groups treated with silymarin and leaf extracts of T. cordifolia. But the groups which received other two extracts such as stem and root, as test drug at the dose of 200mg/kg showed a less signifi cant decrease in the elevated levels of enzymes. Th e results obtained for biochemical parameters are comparable with silymarin, the standard hepatoprotective drug. Th erefore, as like silymarin the leaf extracts have restored the altered level of enzymes signifi cantly. Th e enzyme levels were almost restored to the normal. It was found that the extract decreased the CCl 4 induced elevated levels of the enzymes in group III to XII, indicating the production of structural integrity of hepatocytic cell membrane or regeneration of damaged liver cells by the extract. It was observed that the size of the liver was enlarged in CCl 4 intoxicated rats but it was normal in drug treated groups. A signifi cant reduction in liver weight supports this fi nding.
Normally, AST and ALP are present in high concentration in liver. Due to hepatocyte necrosis or abnormal membrane permeability, these enzymes are released from the cells and their levels in the blood increases. ALT is a sensitive indicator of acute liver damage and elevation of this enzyme in non hepatic diseases is unusual. ALT is more selectively a paranchymal liver enzyme than AST [19] . Assessment of liver function can be made by estimating the activities of serum ALT, AST, ALP and TBL which are enzymes originally present higher concentration in cytoplasm. When there is hepatopathy, these enzymes leak into the blood stream in conformity with the extent of liver damage [20] . Bilirubin is one of the most useful clinical clues to the severity of necrosis and its accumulation is a measure of binding, conjugation and excretory capacity of hepatocyte. Decrease in serum bilirubin after treatment with the extract indicates the eff ectiveness of it in normal functional status of the liver. Histopathological examination of the liver section of the rats treated with toxicant showed intense centrilobular necrosis and vacuolization. Th e rats treated with silymarin and extracts along with toxicant showed sign of protection against these toxicants to considerable extent as evident from formation of normal hepatic cards and absence of necrosis and vacuoles (fi g. 1). Th e preliminary phytochemical studies have revealed the presence of fl avonoids in the extracts of T. cordifolia, which supports the fact that usually fl avonoids show hepatoprotective activity [21] . So in the present study, the hepatoprotective eff ect of T. cordifolia may be due to its fl avonoid content. CCl 4 induced animals signifi cantly lost their body weight and showed reduced food consumption as compared to control group. Animals of drug treated group and standard group showed a signifi cant increase in body weight and food consumption comparably. Th ese fi ndings suggested that extract administered has signifi cantly neutralized the toxic eff ects of CCl 4 and helped in regeneration of hepatocytes [22] . In accordance with these results, it can be said that the leaf extracts of T. cordifolia exhibited a hepato protective eff ect against carbontetrachloride induced hepatotoxicity.
CONCLUSION
Th e plant is used in ayurvedic, "Rasayanas" to improve the immune system and the body resistance against infections. Th e Ayurveda literature reports that it can cause constipation, if taken regularly in high doses; it has no side eff ect and toxicity. Yet the safety and the potential indications in human beings have to be established using modern methods. Th ese studies place this indigenous drug a novel candidate for bioprospection and drug development for the treatment of liver disorders where satisfactory cure managements are still not available. Eff orts are in progress to isolate and characterize the active principle, which is responsible for the hepatoprotective effi cacy of this valuable medicinal plant. Further studies are needed to explain the exact mechanism of action in neutralizing the toxic eff ects.
